The courtroom filled the way courtrooms filled for verdict days — quietly, and then all at once.
The gallery had been at capacity every morning of the trial, but verdict day had a different quality. Not more people — the same people, the forty-seven plaintiffs who had been in those seats since January, the pharmaceutical industry observers who had been watching from the back rows, the press gallery full since seven AM. But the air had changed. The specific tension of six days of deliberation and a jury restart — all of it compressed into the two PM reconvening.
Dr. Rowe sat beside me at the plaintiff's table with her hands flat in front of her and her posture exactly as it had been on the first day of her testimony. Controlled. Present. Not performing calm.
Marcus was to her right. Sarah was behind the bar, standing with the other non-counsel who had permission to be present. Cahill and his two SEC co-counsel were at the adjacent table.
Eleanor Marsh was at the defense table with the Covington team. She'd arrived before I had, which was her custom. She'd been first to everything in this trial except the win.
Judge Chen took the bench at exactly 2:00 PM.
The jury filed in.
Not one of them looked at the defense table.
I registered this automatically, the way I registered everything in a courtroom — not deliberately analyzed, just noticed, stored. Juries who had reached a decision against a party showed a specific body language pattern during verdict entry: they oriented toward the judge, occasionally toward the plaintiff's table, and minimized eye contact with the defense. The effect was unconscious. The pattern was consistent.
I dismissed the analysis before it finished.
I wanted to hear it. Not calculate it. Hear it.
The foreperson was the retired statistician from the voir dire — the woman who had been leaning forward during Dr. Chen's testimony with the recognition of someone who understood what the data discrepancy meant before he finished explaining it.
She stood.
Judge Chen: "Has the jury reached a verdict?"
"We have, Your Honor."
"On the claim of fraud in connection with clinical trial data submitted to the Food and Drug Administration — how do you find?"
The foreperson looked at her paper, then at the gallery.
"We find for the plaintiffs. Defendant Meridian Pharmaceuticals is liable."
The gallery erupted.
Not the contained noise of a professional audience managing itself. Actual eruption — forty-seven people releasing six weeks of held breath and six months before that of lived consequence and years before that of Margaret Holt's arrhythmia and every other damaged life in those seats.
Judge Chen gaveled twice. The sound was sharp and the noise settled, imperfectly.
Dr. Rowe's hands were shaking.
I covered them with mine — one brief, specific gesture. She covered mine with her other hand. We didn't look at each other. We looked forward.
"On compensatory damages for the forty-seven named plaintiffs — what is your award?"
"One hundred twenty-seven million dollars."
I heard Marcus exhale beside me. I heard Cahill's pen click against his notepad.
One hundred twenty-seven million. Medical costs, lost wages, documented harm — each of the forty-seven plaintiffs had provided detailed damages documentation. The jury had awarded approximately the full range of what we'd asked for compensatory.
"On punitive damages — what is your award?"
The foreperson paused.
Not a long pause. Two seconds. The pause of someone who understands the weight of the number they're about to say.
"Three hundred forty million dollars."
Punitive. The jury's statement that what Meridian had done was not a mistake but a choice, and choices that destroyed patient safety deserved consequences beyond compensation.
Total: $467 million.
The courtroom noise started again and Judge Chen gaveled it back down three times before the room reached the managed quiet of people who were overwhelmed and trying to contain it.
Dr. Rowe had both hands pressed to her mouth.
Not crying. She was not going to cry in this courtroom. But she was holding something back with both hands that was larger than her composure had been built to contain.
I stood for Judge Chen's instructions to counsel. The formal procedures that followed a verdict — motions schedules, appeal timelines, judgment entry processes. I nodded in the right places. Some portion of my professional attention was managing the procedural requirements. The rest was simply present in the room, in the specific weight of the moment.
Eleanor Marsh was motionless at the defense table throughout.
She had tried the case with the excellence her reputation required. She had built the best defense the evidence allowed. The evidence had not allowed for a better one than she'd built, and she'd lost because the evidence was what it was: a line of code changed on March 14th, 2011, six days before an FDA application, not by the vendor who had performed real work on a different set of parameters, but by someone who had read an email about a problem on March 7th and had fixed the problem by making it disappear from the count.
She gathered her files when the judge released counsel. She did not look toward the plaintiff's table.
The press had been waiting on the courthouse steps since before the reconvening notice went out, which meant someone at the courthouse had an informal arrangement with a media contact, which was not Scott's problem right now.
Dr. Rowe stood beside me.
I did not hand her notes or a prepared statement. We'd agreed two weeks ago that she would stand here and be present, and I would speak, and the combination of her visible presence and my restraint would produce the right picture.
"This verdict says that pharmaceutical companies cannot manipulate clinical trial data and hide behind statistical complexity," I said. "Dr. Rowe's courage in coming forward made this possible. The forty-seven plaintiffs who remained through six weeks of testimony made this possible." A pause. "Justice looks like this: slow, difficult, and worth every moment."
Three questions from the press. I answered them the same way I'd answered every press interaction during the trial: specific, factual, no editorializing about Meridian's leadership, no speculation about appeals. The verdict spoke.
I walked back to the car.
My phone had already accumulated seventeen messages since the verdict was announced. I looked at one of them.
Harvey: 467M. Not bad, Roden.
I typed back: Not bad at all.
Donna was at the door.
Not waiting in the hallway, not doing something else when I arrived. At the door, which meant she'd heard through a news alert before I could call and had been standing there since.
She didn't say anything. She pulled me inside.
We sat on the couch in the apartment that had been ours for four years. The kitchen wall with its pencil marks behind us. The city doing its late-afternoon thing outside the windows.
"You did it," she said.
"We're doing it. Everything. Together."
She leaned her head against my shoulder.
Not the triumphant moment the trial coverage would describe — the big pharmaceutical verdict, the landmark case, the headline numbers. This was the part after. The specific quiet of having spent everything you had on something that mattered and discovering it was enough.
The apartment was home. The case was over.
Everything that came next was different.
A LOT More chapters reign FREE upon unwrittenrealm.com.
• Normal | $8 — 15 chapters ahead
• Advanced | $11 — 20 chapters ahead
• Overlord | $19 — 25 chapters ahead, plus request a refinement (plot, character, system) on any of my novels
patreon.com/TheFinex5
▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰
― DECREE ―
More chapters reign FREE upon unwrittenrealm.com.
The throne acknowledges.
▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰